SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020579
Filing Date
2018-11-13
Accepted
2018-11-13 16:19:23
Documents
59
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sphs20180930_10q.htm 10-Q 1004996
2 EXHIBIT 31.1 ex_128768.htm EX-31.1 11200
3 EXHIBIT 31.2 ex_128769.htm EX-31.2 12355
4 EXHIBIT 32.1 ex_128770.htm EX-32.1 6771
5 EXHIBIT 32.2 ex_128771.htm EX-32.2 6975
  Complete submission text file 0001437749-18-020579.txt   4015940

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sphs-20180930.xml EX-101.INS 775178
7 XBRL TAXONOMY EXTENSION SCHEMA sphs-20180930.xsd EX-101.SCH 46200
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sphs-20180930_cal.xml EX-101.CAL 29769
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sphs-20180930_def.xml EX-101.DEF 274011
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sphs-20180930_lab.xml EX-101.LAB 228455
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sphs-20180930_pre.xml EX-101.PRE 292843
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 181178232
SIC: 2834 Pharmaceutical Preparations